Table 1 Clinical characteristics of 10 Japanese cases with stage III esophageal basaloid squamous cell carcinoma: site, morphology, metastasis, survival period, current status and treatment
Site | Morphology | Metastasis | Survival period (months) | Current status | Treatment |
|---|---|---|---|---|---|
Upper and middle | Type 1 (Erosive elevation) | Bone | 13 | Dead | Surgery alone |
Lower | Type 2 | Lung, liver, lymph nodes | 8 | Dead | Chemoradiotherapy after surgery |
Upper | Type 2 | Lung, brain | 22 | Dead | Chemotherapy after surgery |
Lower | Type 3 | Liver | 10 | Dead | Surgery alone |
Lower | Type 1 | Liver | 36 | Alive | 1. Chemotherapy after surgery 2. Chemotherapy after liver metastasis resection |
Middle | Type 1 | Liver, lymph nodes | 9 | Dead | Surgery after pre-operative chemotherapy |
Lower | Type 1 | Liver | 27 | Alive | 1. Surgery 2. Surgery after hepatic arterial injection chemotherapy for liver metastasis |
Middle | Type 2 | Liver, lymph nodes | 10 | Dead | Chemotherapy after surgery |
None | None | Mediastinal lymph modes, solitary lung | 61 | Alive | 1. Surgery 2. Mediastinal lymph node radiation 3. Surgery after chemotherapy for lung metastasis |
Upper | Type 3 | None | 25 | Alive | Radiotherapy alone |